Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Midgut Neuroendocrine Tumors × NET × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 206 Carcinoid Tumor 26 Neoplasms 22 Pancreatic Neoplasms 16 Gastro-enteropancreatic neuroendocrine tumor 13 Carcinoma, Neuroendocrine 11 Carcinoma 11 Adenoma, Islet Cell 11 Neoplasm Metastasis 10 Colorectal Neoplasms 9 Lung Neoplasms 8 Serotonin Syndrome 7 Prostatic Neoplasms 7 Adenocarcinoma 7 Pheochromocytoma 6 Gastrointestinal Neoplasms 6 Colonic Neoplasms 6 Breast Neoplasms 6 Thyroid Neoplasms 5 Stomach Neoplasms 5 Somatostatinoma 5 Neuroblastoma 5 Melanoma 5 Gastroenteropancreatic Neuroendocrine Tumors 5 Cholangiocarcinoma 5 Carcinoma, Renal Cell 5 Vipoma 4 Sarcoma 4 Rectal Neoplasms 4 Paraganglioma 4

Interventions

Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03667092 2025-04-10

GENEBIOLuNET

University Hospital, Toulouse

Phase NA Completed

Midgut Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡